AN2 Therapeutics
ANTX
ANTX
45 hedge funds and large institutions have $41.7M invested in AN2 Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 14 closing their positions.
Holders
45
Holders Change
-9
Holders Change %
-16.67%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
13
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OCA
1
Octagon Capital Advisors
New York
|
$6.92M |
| 2 |
FLSM
2
Frazier Life Sciences Management
Palo Alto,
California
|
$4.49M |
| 3 |
3
Millennium Management
New York
|
$1.13M |
| 4 |
4
Goldman Sachs
New York
|
$482K |
| 5 |
5
Two Sigma Advisers
New York
|
$290K |
